Renal tubular injury associated with anagrelide use-Reference-Cited by-同舟云学术

Renal tubular injury associated with anagrelide use

Published:2005-02-22 Issue:5 Volume:20 Page:988-990
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Rodwell Graham E. J.,Troxell Megan L.,Lafayette Richard A.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/20/5/988/5239528/gfh726.pdf

Reference5 articles.

1. Tomer A. Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia. Blood2002; 99: 1602–1609

2. Anagrelide Study Group. Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group. Am J Med1992; 92: 69–76

3. Schafer AI. Thrombocytosis. N Engl J Med2004; 350: 1211–1219

4. Birgegard G, Bjorkholm M, Kutti J et al. Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. Haematologica2004; 89: 520–527

5. Roberts Pharmaceutical Corporation. Agrylin (anagrelide) package insert. Roberts Pharmaceutical Corp., Eatontown, NJ: 1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal tubular necrosis associated with anagrelide administration: a case report;CEN Case Reports;2024-04-24

2. Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function;Pharmacology;2021

3. Anagrelide;Meyler's Side Effects of Drugs;2016

4. Renal extramedullary hematopoiesis: interstitial and glomerular pathology;Modern Pathology;2015-10-09

5. Anagrelide: 20 years later;Expert Review of Anticancer Therapy;2009-01